scindu funding
Wszystkie nabory

Prevention and mitigation of misuse of synthetic biology for bioterrorism purposes

Horyzont Europa · Temat konkursu

HORIZON-CL3-2026-01-FCT-06

Podsumowanie

Polska firma może skorzystać z tego naboru na B+R.

Funds collaborative research on synthetic biology misuse, bioterrorism threats, monitoring and safeguards for policymakers, researchers, biotech companies and security practitioners.

Kto może złożyć wniosek
Firma może być liderem: SME, large company, startup, research org, university, NGO, public body.
Kwota
3 mln € na projektBudżet całkowity 3 000 000 €
Termin
05.11.2026 01:00 CETza 12 dni
Status
Otwartyotwarty 6 maj 2026
Otwórz na portaluZarejestruj się, aby zachować nabór

Ocena maszynowa na podstawie tekstu naboru; warunki sprawdź u źródła.

Opis

Expected Outcome:

Project results are expected to contribute to all of the following expected outcomes:

• Increased understanding of European policy makers, research community, biotech companies, and relevant security practitioners of the threat of bioterrorism and of synthetic biology, including a thorough lawful analysis of what needs to be monitored in this context, what needs to be regulated and how;

• Awareness raised within the related scientific community how research in synthetic biology can be used for malicious purposes.

Scope:

The rising threat of bioterrorism is driven by recent scientific advancements, notably by growing accessibility of synthetic biology, genetic engineering, related commercial services and public databases, which in turn enhance their obtainability to non-state actors and individuals with malicious intentions. The proliferation of do-it-yourself biohacking and community laboratories, including gene editing and sequencing technology, dropping costs of equipment and increased simplicity of use may inadvertently facilitate knowledge and skills dissemination about biological threats and open new pathways for bioterrorism. Challenges in detection, particularly the lengthy incubation periods of biological agents, underscore the urgent need for improved identification technologies to allow for timely intervention and reduce potential mass casualties, considering both characterization through advanced tools by expert labs and simple deployable methods. Given that properly weaponized biological agents can be more lethal than nuclear weapons, their cross-border implications warrant focused attention. Recent incidents involving biotoxins across various European countries illustrate the feasibility of biological attacks. The increasing weaponisation of drones highlights an alarming trend that could extend to biological agents, further complicating threat landscapes. The potential economic and social consequences of biological attacks necessitate robust prevention and preparedness measures to mitigate overwhelming impacts on healthcare systems and society at large.

Proposals are expected to address, in a lawful manner, the emerging threats of bioterrorism in Europe, particularly in the context of synthetic biology. Recognising bioterrorism as a low-probability but high-impact event, consortia should review current and future risks, flag areas requiring reinforced monitoring, as well as identify missing regulatory frameworks necessary for ensuring public security and safety. Furthermore, proposals should bring together diverse consortia to enhance our understanding, prevention, preparedness, and response to bioterrorism and create a comprehensive approach to this pressing issue.

Coordination among the successful proposals from this topic should be envisaged to avoid duplication and to exploit complementarities as well as opportunities for increased impact. In this topic the integration of the gender dimension (sex and gender analysis) in research and innovation content should be addressed only if relevant in relation to the objectives of the research effort.

Proposals funded under this topic are expected to provide ideas on how they would engage with the Europol Innovation Lab during the lifetime of the project. Similarly, if the proposals concern drug-related issues, they are expected to engage with the EU Drugs Agency during the lifetime of the project, including validating the outcomes.

Finally, proposals are expected to address all applicable considerations expressed in the Introduction of the Fighting Crime and Terrorism Destination.

Technology Readiness Level - Technology readiness level expected from completed projects

Activities are expected to achieve TRL 4-5 by the end of the project – see General Annex B.

Kto może złożyć wniosek – szczegóły
Typy wnioskodawców
SME, Large company, Startup, Research org, University, NGO, Public body
Cel
Badania i innowacje
Znaczenie dla B+R
3 z 3
Polska kwalifikuje się
Tak
Ograniczenie krajów
—
Region
Dowolny
Konsorcjum
Wymagane
Poziom gotowości (TRL)
4-5
Tematy
  • Synthetic biology
  • Bioterrorism prevention
  • Biosecurity
  • Genetic engineering misuse

Ocena maszynowa na podstawie tekstu naboru; warunki sprawdź u źródła. 23 paź 2026

Warunki5

Fakty wyodrębnione z dokumentów źródłowych w przeglądzie danych Scindu. Każda wartość ma własne warunki. Brak danych oznacza, że źródło nie podaje wartości, a nie zero ani brak limitu.

Typ wnioskodawcy
The topic refers applicants to General Annex B. Unless a specific topic condition provides otherwise, a consortium must include three independent legal-entity beneficiaries established in different countries: at least one in an EU Member State and two others in different EU Member States or Associated Countries. Affiliated entities do not count toward that minimum. This is the general default; topic-specific exceptions and full applicant eligibility remain to be checked.
Zakres projektu
Type of Action: Research and Innovation Actions.
Inny warunek
The General Annexes state that for lump-sum and unit grants, the funding rate is already applied in the methodology used to fix the amounts and is not shown in the grant agreement. The action-type maximum rate below is therefore a general Horizon Europe ceiling, not an additional calculation to apply to this topic’s fixed lump-sum amount.
Poziom gotowości technologicznej na koniec, maksimum
5 TRL

Expected technology readiness level by project end; this describes project outcomes, not applicant eligibility or a hiring condition.

Poziom gotowości technologicznej na koniec, minimum
4 TRL

Expected technology readiness level by project end; this describes project outcomes, not applicant eligibility or a hiring condition.

Kwoty i koszty7
Budżet orientacyjny
3 000 000 €

Budżet tematu z tabeli budżetowej portalu. Limity na projekt i ryczałty są w warunkach konkursu.

Koszt kwalifikowalny
The topic specifically adopts a Horizon Europe lump-sum grant. The applicable Lump Sum MGA treats the grant as a contribution for completion of work packages; eligibility depends on the amounts in Annex 2 and proper completion/implementation (or results achieved) during the action period. This is not reimbursement of each beneficiary’s actual payroll or service invoices, and does not establish a salary entitlement.
Koszt kwalifikowalny
For project-based Horizon Europe lump sums, the 2026 Commission guidance requires realistic estimates per cost category, beneficiary/affiliated entity and work package. Personnel-cost estimates are permitted only for cost items that would qualify under the corresponding actual-cost eligibility rules, and must follow normal practice, be reasonable, and be necessary and in line with proposed activities. These are inputs for the fixed lump-sum estimate; actual payroll is not separately reimbursed or reported as a claim under the lump-sum grant.
Koszt kwalifikowalny
For the applicable lump-sum model, the contribution is set out in the grant agreement Annex 2 and broken down by participant and work package; payment eligibility is tied to work-package completion and proper implementation or achieved results during the action period, as stated in the agreement. Actual underlying payroll or subcontract cost is not reimbursed invoice-by-invoice under this form.
Intensywność wsparcia, maksimum
100 percent of eligible costs

General Annex maximum for RIA action type; funding rate is fixed in the grant agreement, may differ under specific topic conditions, and because this topic uses lump sum the rate is already applied in amount methodology. This is an action-type ceiling, not an independently payable addition to the expected contribution.

Oczekiwane dofinansowanie projektu, do
3 000 000 €

Indicative expected EU contribution per project stated as around EUR 3 million; this is an estimate, not a minimum, maximum, or binding per-project cap. Applicants may request a different amount.

Oczekiwane dofinansowanie projektu, od
3 000 000 €

Indicative expected EU contribution per project stated as around EUR 3 million; this is an estimate, not a minimum, maximum, or binding per-project cap. Applicants may request a different amount.

Alokacja tematu
3 000 000 €

Indicative total topic allocation stated as an amount in EUR million in the call overview; it is distinct from the expected EU contribution per project. Allocation scope: per topic.

Personel i usługi4

  • Inna rola

    Koszt personelu, który grant może sfinansować

    Natural persons working under a direct contract other than an employment contract may be included as personnel cost estimates only when assigned to the action, working under conditions similar to an employee, and the result belongs to the beneficiary (unless otherwise agreed). The estimate follows actual-cost eligibility; no role or pay rate is specified.

  • Inna rola

    Koszt personelu, który grant może sfinansować

    Costs for employees under an employment contract or equivalent appointing act and assigned to the action; any estimated amount is only a budget input subject to the call’s lump-sum methodology and applicable actual-cost eligibility rules. This is not a prescribed job, required hire, headcount or salary rate.

  • Inna rola

    Koszt personelu, który grant może sfinansować

    Seconded-person personnel cost estimates are conditional on assignment to the action, employee-like working conditions and ownership of the work result by the beneficiary (unless otherwise agreed), and must correspond to actual costs and not differ significantly from comparable employee tasks. This cost category does not prescribe a job or salary.

  • Inna rola

    Koszt personelu, który grant może sfinansować

    The work of an SME owner or natural person beneficiary who receives no salary may be declared as personnel costs only if general eligibility conditions are met and the amount is calculated as a unit cost under Annex 2a. No hourly/monthly amount is asserted here.

Dokumenty źródłowe5
Dane naboru
Otwarcie
6 maj 2026
Tryb terminów
Single-stage
Program
Horyzont Europa · 2021 - 2027
Konkurs
HORIZON-CL3-2026-01 · Civil Security for Society 2026
Rodzaje działań
HORIZON Research and Innovation Actions
Słowa kluczowe
  • biotech
  • bioterrorism
  • crime
  • mitigation
  • research
  • security practitioners
  • synthetic biology
Źródło
ec.europa.eu
Sprawdzono
24 paź 2026
Aktualizacja portalu
23 paź 2026
Status przeglądu
Przegląd częściowy
Przejrzano
23 paź 2026

To skrót ze strony źródłowej, nie tekst urzędowy. Kwalifikowalność, warunki i system składania wniosków są u źródła.